Project Grant D43TW012467
Award Date
5/1/24
Completion Date
4/30/29
Dollars Obligated
$547K
Funding Federal Agency
National Institute of Allergy and Infectious Diseases
Awarding Federal Agency
Fogarty International Center
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
South Africa
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support a comprehensive study to characterize the immune response to tuberculosis (TB) across different disease states. The $517,185 award to the University of California, Davis, with a sub-award to Stellenbosch University in South Africa, will fund the integration of single-cell multi-omics profiling and ancestry-adjusted expression...
This federal Project Grant award, funded by the John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training), provides $106,160 over 5 years to researchers at Stellenbosch University in South Africa. The award aims to investigate the role of DNA methylation in the stress response and persistence of Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis. Specifically, the project will: (1) demonstrate how DNA methylation impacts MTB's stress...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $1,185,782 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Alabama at Birmingham (UAB) to establish a global research resource for studying human tuberculosis (TB). The grant will support two key services: (1) pathological, cellular, structural, and/or genetic analysis of resected human TB or postmortem lung tissue, and (2) dissemination of this tissue to the global...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA Program 93.855 - Allergy and Infectious Diseases Research - totals $718,758 over the period of September 1, 2024 to August 31, 2025. The grant aims to explore the use of an IL-21-IgFc fusion protein as a host-directed immunotherapy to enhance immunity in individuals with tuberculosis (TB)/HIV co-infection. Specifically, the research will investigate whether supplementing...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), is supporting a $2,817,044 research program on "Systems Genetics of Tuberculosis" over 5 years. The project aims to use a mouse model system and human clinical samples to identify biological pathways influencing tuberculosis infection outcomes. Key activities include:
Leveraging genetic diversity in mouse and bacterial...
This $899,894 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to investigate the early immune cell interactions and signaling pathways that influence the progression of tuberculosis (TB) in co-infection with HIV. The prime recipient, Washington University, is collaborating with Massachusetts General Hospital and the University of Pittsburgh to define how type I interferon (IFN) and...
This $737,342 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will fund the development and validation of advanced imaging technologies to enable the ultrasensitive detection of Mycobacterium tuberculosis (MTB) infection. The key objectives are to:
Develop new imaging methods capable of detecting single MTB bacteria in vitro and in vivo, building upon the research team's preliminary work...
This $1,011,348 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how the first interactions of Mycobacterium tuberculosis (M.TB) with the human alveolar environment, particularly alveolar lining fluid (ALF) and alveolar cells, are impacted by HIV infection. The research aims to determine how M.TB exposure to ALF from people living with HIV leads to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $127,980 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The award aims to integrate genomic and spatial data to improve the targeting of community-based tuberculosis (TB) screening and prevention interventions in high-burden settings. Key research objectives include refining subnational TB prevalence estimates, using genomic data to...
This $1,314,701 federal Project Grant award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award is funding research to address gaps in optimizing dolutegravir-based antiretroviral therapy (ART) for children and adolescents.
The primary awardee is the University of Florida, Division of Sponsored Research, which will be conducting the research...